Antihypertensive Efficacy and Tolerability of Two Fixed-Dose Combinations of Valsartan and Hydrochlorothiazide Compared with Valsartan Monotherapy in Patients with Stage 2 or 3 Systolic Hypertension: An 8-Week, Randomized, Double-Blind, Parallel-Group Trial
- 31 July 2005
- journal article
- clinical trial
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 27 (7), 1013-1021
- https://doi.org/10.1016/j.clinthera.2005.07.010
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Recent hypertension trials: Implications and controversiesJournal of the American College of Cardiology, 2005
- Angioedema Associated With Angiotensin-Converting Enzyme Inhibitor UseArchives of Internal Medicine, 2004
- Assessment of the optimal daily dose of valsartan in patients with hypertension, heart failure, or bothClinical Therapeutics, 2004
- Hypertension control – an old song resungBlood Pressure, 2004
- A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: The Val-Syst studyClinical Therapeutics, 2003
- 2003 European Society of Hypertension???European Society of Cardiology guidelines for the management of arterial hypertension*Journal Of Hypertension, 2003
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 ReportJAMA, 2003
- Valsartan/Hydrochlorothiazide is Effective in Hypertensive Patients Inadequately Controlled by Valsartan MonotherapyBlood Pressure, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Cardiovascular protection and blood pressure reduction: a meta-analysisThe Lancet, 2001